Mesoblast Limited MESO

$ 15.79 7.93%

Annual report 2022
added 08-31-2022

Mesoblast Limited Balance Sheet 2011-2024 | MESO

Annual Balance Sheet Mesoblast Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-50.2 M	-126 M	-68.8 M	30.9 M	21.6 M	-45.8 M	-80.9 M	-144 M	-196 M	-315 M	-207 M	-263 M
Long Term Debt	7.08 M	8.48 M	57 M	67.3 M	59.4 M	-	-	-	-	-	-	-
Long Term Debt Current	3.19 M	2.76 M	3.52 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	114 M	69 M	-	127 M	122 M	102 M	126 M	346 M	285 M	203 M	197 M	217 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	165 M	163 M	184 M	171 M	146 M	139 M	156 M	409 M	328 M	253 M	242 M	247 M
Deferred Revenue	-	-	-	-	-	-	-	19.5 M	15.9 M	16.2 M	28.2 M	27.1 M
Retained Earnings	-739 M	-648 M	-549 M	-470 M	-380 M	-345 M	-268 M	-298 M	-179 M	-97.8 M	-36.2 M	35 M
Total Assets	662 M	745 M	734 M	652 M	692 M	656 M	684 M	1.02 B	899 M	884 M	720 M	763 M
Cash and Cash Equivalents	60.4 M	137 M	129 M	50.4 M	37.8 M	45.8 M	80.9 M	-	-	-	-	-
Book Value	497 M	581 M	549 M	481 M	546 M	517 M	528 M	609 M	572 M	630 M	479 M	516 M
Total Shareholders Equity	497 M	581 M	549 M	481 M	546 M	517 M	528 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Mesoblast Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	8.05 M	7.94 M	7.56 M	8.48 M	6.48 M	6.51 M	7.05 M	6.32 M	5.76 M	6.68 M	3.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	112 M	111 M	69.2 M	69 M	66.6 M	77.5 M	86.4 M	94.1 M	101 M	112 M	109 M	127 M	130 M	130 M	-	122 M	-	-	-	102 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	165 M	169 M	162 M	163 M	165 M	169 M	174 M	184 M	178 M	189 M	179 M	171 M	175 M	164 M	-	146 M	-	-	-	139 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-717 M	-696 M	-670 M	-648 M	-626 M	-599 M	-573 M	-549 M	-516 M	-501 M	-476 M	-470 M	-449 M	-424 M	-	-380 M	-	-	-	-345 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	682 M	704 M	722 M	745 M	766 M	687 M	713 M	734 M	666 M	690 M	654 M	652 M	676 M	688 M	-	692 M	-	-	-	656 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	76.8 M	94.8 M	116 M	137 M	158 M	77.5 M	108 M	129 M	60.1 M	81.3 M	34.5 M	50.4 M	70.4 M	77 M	55.1 M	37.8 M	59.5 M	47.4 M	-	45.8 M	-	-	-	80.9 M	-	-	-	111 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	517 M	536 M	560 M	581 M	601 M	519 M	539 M	549 M	488 M	501 M	475 M	481 M	501 M	525 M	-	546 M	-	-	-	517 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	517 M	536 M	560 M	581 M	601 M	519 M	539 M	549 M	488 M	501 M	475 M	481 M	501 M	525 M	528 M	546 M	556 M	576 M	-	517 M	-	-	-	528 M	-	-	-	468 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency